GSK-nyheder: Lægemiddelgiganten leder efter opkøb, der går ind i 2023

FORSKNINGSTREKANTPARK – GSK is on the prowl for more acquisitions in 2023, a senior executive tells The Financial Times.

“GSK on hunt for attractive biotechs ‘hiding in plain sight,” The FT reports.

“Chief commercial officer Luke Miels looking at targets worth up to $2.5bn,” the paper adds.

Læs hele historien på: https://www.ft.com/content/16017258-368d-49eb-8555-4603a63b6726